SAPIRSTEIN JAMES bought INMB

September 15, 2026 · Form 4 insider transaction

SAPIRSTEIN JAMES bought 100,000 shares of INmune Bio Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
100,000
Price
$0.00
Total value
N/A
Role
SecurityStock Options
Transaction codeA: Grant or award
Transaction dateSeptember 15, 2026
Filing dateSeptember 17, 2026
Shares owned after100,000
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represent an initial award of options in consideration for the Reporting Person's service to the Board of Directors of INmune Bio, Inc. Granted pursuant to the Issuer's Third Amended and Restated 2021 Stock Incentive Plan. The options will vest in 36 equal installments over three (3) years (1/36 per month) beginning one month after the grant date until the option is 100% vested which shall occur on the three-year anniversary of the date of grant.

View the original Form 4 on SEC EDGAR
SAPIRSTEIN JAMES bought INMB: September 15, 2026 | Insider Trading Screener